You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 5, May 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Normalization of Blunted Lymphocyte β-Adrenergic Responsivity in Melancholic Inpatients by a Course of Electroconvulsive Therapy

J. John Mann, MD; John C. Mahler, MD; Philip J. Wilner, MD; James P. Halper, MD; Richard P. Brown, MD; Katherine S. Johnson, RN; James H. Kocsis, MD; Jaw-Sy Chen, MD

Arch Gen Psychiatry. 1990;47(5):461-464.


Abstract

• Electroconvulsive therapy has been reported to desensitize brain β-adrenergic receptors in rodents, but this effect has not been studied in man. We examined the effect of a course of electroconvulsive therapy on lymphocyte β-adrenergic responsivity in 19 inpatients with melancholia. Before treatment, β adrenergic cyclic adenosine monophosphate response to isoproterenol was significantly blunted in the patients compared with controls. Following a course of electroconvulsive therapy, β-adrenergic responsivity increased such that patients no longer differed from controls. Thus, blunted lymphocyte β-adrenergic responsivity is a state-dependent effect of melancholia that can be corrected by a therapeutic course of electroconvulsive therapy. The effect of electroconvulsive therapy on this β-adrenergic system is in the opposite direction to that reported for rodent forebrain, where electroconvulsive therapy causes desensitization, and may reflect differences between peripheral and central effects, species differences, or disease effects.



Author Affiliations

From the Laboratory of Psychopharmacology, Department of Psychiatry, Cornell University Medical College, New York, NY. Dr Mann is now with the Laboratories of Neuropharmacology, University of Pittsburgh (Pa).


Footnotes

Accepted for publication September 14, 1989.

Reprint requests to Laboratories of Neuropharmacology, Department of Psychiatry, University of Pittsburgh, Western Psychiatric Institute and Clinic, 3811O'Hara St, Pittsburgh, PA 15213 (Dr Mann).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.